134 related articles for article (PubMed ID: 35817293)
1. Design and preparation of N-linked hydroxypyridine-based APJ agonists.
Richter JM; Alex Bates J; Gargalovic P; Onorato JM; Generaux C; Wang T; Gordon DA; Wexler RR; Finlay HJ
Bioorg Med Chem Lett; 2022 Oct; 73():128882. PubMed ID: 35817293
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
[TBL] [Abstract][Full Text] [Related]
3. Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists.
Tora G; Jiang J; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux C; Xu C; Galella MA; Wang T; He Y; Wexler RR; Finlay HJ
Bioorg Med Chem Lett; 2021 Oct; 50():128325. PubMed ID: 34403724
[TBL] [Abstract][Full Text] [Related]
4. Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ.
Myers MC; Bilder DM; Cavallaro CL; Chao HJ; Su S; Burford NT; Nayeem A; Wang T; Yan M; Langish RA; Dabros M; Li YX; Rose AV; Behnia K; Onorato JM; Gargalovic PS; Wexler RR; Lawrence RM
Bioorg Med Chem Lett; 2020 Apr; 30(7):126955. PubMed ID: 32035698
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate.
Johnson JA; Kim SH; Jiang J; Phillips M; Schumacher WA; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux C; He Y; Chen XQ; Xu C; Galella MA; Wang T; Gordon DA; Wexler RR; Finlay HJ
J Med Chem; 2021 Mar; 64(6):3086-3099. PubMed ID: 33689340
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Hydroxypyrimidinone Compound (
Meng W; Pi Z; Brigance R; Rossi KA; Schumacher WA; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux CN; Wang T; Wexler RR; Finlay HJ
J Med Chem; 2021 Dec; 64(24):18102-18113. PubMed ID: 34855405
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular response to small-molecule APJ activation.
Ason B; Chen Y; Guo Q; Hoagland KM; Chui RW; Fielden M; Sutherland W; Chen R; Zhang Y; Mihardja S; Ma X; Li X; Sun Y; Liu D; Nguyen K; Wang J; Li N; Rajamani S; Qu Y; Gao B; Boden A; Chintalgattu V; Turk JR; Chan J; Hu LA; Dransfield P; Houze J; Wong J; Ma J; Pattaropong V; Véniant MM; Vargas HM; Swaminath G; Khakoo AY
JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32208384
[TBL] [Abstract][Full Text] [Related]
8. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel small molecule agonist scaffold for the APJ receptor.
Narayanan S; Maitra R; Deschamps JR; Bortoff K; Thomas JB; Zhang Y; Warner K; Vasukuttan V; Decker A; Runyon SP
Bioorg Med Chem; 2016 Aug; 24(16):3758-70. PubMed ID: 27369451
[TBL] [Abstract][Full Text] [Related]
10. Biphenyl Acid Derivatives as APJ Receptor Agonists.
Su S; Clarke A; Han Y; Chao HJ; Bostwick J; Schumacher W; Wang T; Yan M; Hsu MY; Simmons E; Luk C; Xu C; Dabros M; Galella M; Onorato J; Gordon D; Wexler R; Gargalovic PS; Lawrence RM
J Med Chem; 2019 Nov; 62(22):10456-10465. PubMed ID: 31724863
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
[TBL] [Abstract][Full Text] [Related]
12. Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation.
Reed AB; Lanman BA; Holder JR; Yang BH; Ma J; Humphreys SC; Wang Z; Chan JCY; Miranda LP; Swaminath G; Allen JG
Bioorg Med Chem Lett; 2020 Nov; 30(21):127499. PubMed ID: 32858124
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor.
Narayanan S; Dai D; Vyas Devambatla RK; Albert V; Bruneau-Latour N; Vasukuttan V; Ciblat S; Rehder K; Runyon SP; Maitra R
Bioorg Med Chem; 2022 Jul; 66():116789. PubMed ID: 35594649
[TBL] [Abstract][Full Text] [Related]
14. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression.
Atluri P; Morine KJ; Liao GP; Panlilio CM; Berry MF; Hsu VM; Hiesinger W; Cohen JE; Joseph Woo Y
Cell Mol Biol Lett; 2007; 12(1):127-38. PubMed ID: 17119870
[TBL] [Abstract][Full Text] [Related]
15. Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling.
Galon-Tilleman H; Yang H; Bednarek MA; Spurlock SM; Paavola KJ; Ko B; To C; Luo J; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
J Biol Chem; 2017 Feb; 292(5):1925-1933. PubMed ID: 27994053
[TBL] [Abstract][Full Text] [Related]
16. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure.
Barnes GD; Alam S; Carter G; Pedersen CM; Lee KM; Hubbard TJ; Veitch S; Jeong H; White A; Cruden NL; Huson L; Japp AG; Newby DE
Circ Heart Fail; 2013 May; 6(3):482-91. PubMed ID: 23519586
[TBL] [Abstract][Full Text] [Related]
17. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
18. Identification of potent pyrazole based APELIN receptor (APJ) agonists.
Narayanan S; Vasukuttan V; Rajagopal S; Maitra R; Runyon SP
Bioorg Med Chem; 2020 Feb; 28(4):115237. PubMed ID: 31948845
[TBL] [Abstract][Full Text] [Related]
19. The apelin/APJ system as a therapeutic target in metabolic diseases.
Castan-Laurell I; Masri B; Valet P
Expert Opin Ther Targets; 2019 Mar; 23(3):215-225. PubMed ID: 30570369
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
